Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2010
08/19/2010US20100210617 Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase Inhibitors
08/19/2010US20100210612 Detection of esr1 amplification in endometrium cancer and ovary cancer
08/19/2010US20100210597 C21-Deoxy Ansamycin Derivatives as Antitumor Agents
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
08/19/2010US20100210583 Novel antifolate combination therapies
08/19/2010US20100210572 Hydrolysate of crocin
08/19/2010US20100210568 Thyrotropin releasing hormone for therapeutic applications
08/19/2010US20100210567 Use of a tuftsin as a therapeutic agent
08/19/2010US20100210559 Trap-14 as a therapeutic agent
08/19/2010US20100210558 Minigastrin as a therapeutic agent
08/19/2010US20100210557 Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agent
08/19/2010US20100210555 Use of a laminin peptide as a therapeutic agent
08/19/2010US20100210554 Therapeutic uses of gastrin- 1 and g- pen-grgdspca
08/19/2010US20100210539 Use of peptide ll-37 as a therapeutic agent
08/19/2010US20100210537 Use of a defensin peptide as a therapeutic agent
08/19/2010US20100210535 Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereof
08/19/2010US20100210534 Use of a peptide as a therapeutic agent
08/19/2010US20100210533 Use of urocortin and corticotropin-releasing factor as therapeutic agents
08/19/2010US20100210529 P53 peptide vaccine
08/19/2010US20100210525 Combined preparation of a thiazide diuretic and a loop diuretic
08/19/2010US20100210524 Novel estrogen receptor ligands
08/19/2010US20100210522 Method for determining presence of cancer in a sample by assaying for expression of dppa-2 nucleotide sequences
08/19/2010US20100210519 Peptide slow-release formulations
08/19/2010US20100210518 Peg-lipid conjugates for increasing the solubility of drug compounds
08/19/2010US20100210517 Cyclic receptor-associated protein (rap) peptides
08/19/2010US20100210514 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210513 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210511 Combination VEGFR2 Therapy with Temozolomide
08/19/2010US20100210476 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them
08/19/2010US20100209543 Compositions and methods of use
08/19/2010US20100209537 Metal complexes with anticancer activity
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209519 Pharmaceutical composition for inhalation delivery and fabrication method thereof
08/19/2010US20100209495 Granulates, process for preparing them and pharmaceutical products containing them
08/19/2010US20100209494 Liposomes and Uses Thereof
08/19/2010US20100209493 HLA-A2 Tumor Associated Antigen Peptides and Compositions
08/19/2010US20100209488 Protein kinase modulating compounds and methods for making and using them
08/19/2010US20100209487 Nicked or gapped nucleic acid molecules and uses thereof
08/19/2010US20100209479 Compositions And Methods For Treating Cancer
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209456 Treating neoplasms with neurotoxin
08/19/2010US20100209444 MAGE3 Polypeptides
08/19/2010US20100209443 Vaccine for the Prevention of Breast Cancer Relapse
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209440 Targeted Delivery of siRNA
08/19/2010US20100209438 OVR110 Antibody Compositions and Methods of Use
08/19/2010US20100209433 Methods for the diagnosis and for the treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
08/19/2010US20100209432 Monoclonal antibodies against glypican-3
08/19/2010US20100209431 Metal triangulo compound and methods of using the same
08/19/2010US20100209429 Peptides and methods for the treatment of gliomas and other cancers
08/19/2010US20100209426 Inhibitors of progastrin-induced repression of icat for treating and/or preventing colorectal cancer, adenomatous polyposis or metastasis displaying progastrin-secreting cells and cells in which the beta-catenin/tcf-mediated transcriptional pathway is constitutively active
08/19/2010US20100209421 Targeting pax2 for the treatment of breast cancer
08/19/2010US20100209420 Methods of treating cancer using pyridopyrimidinone inhibitors of p13k alpha
08/19/2010US20100209418 Solid Forms of a Raf Kinase Inhibitor
08/19/2010US20100209415 Chemotherapeutic methods and compositions
08/19/2010US20100209414 Methods and Compositions Related to Cyclic Peptide Synthesis
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209388 Nutraceutical composition and method of use for treatment / prevention of cancer
08/19/2010US20100209386 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
08/19/2010US20100209359 Medicated chewing gum
08/19/2010US20100209355 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
08/19/2010US20100209354 Organic/inorganic hybrid nanoparticulates made from iron carboxylates
08/19/2010US20100209345 Fluorinated Ligands for Targeting Peripheral Benzodiazepine Receptors
08/19/2010US20100209343 Methods and kits for diagnosis of cancer and prediction of therapeutic value
08/19/2010US20100209342 Apcdd1 inhibitors for treating, diagnosing or detecting cancer
08/19/2010US20100209340 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
08/19/2010CA2789365A1 Methods for treating non-small cell lung cancer using 5-azacytidine
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2752623A1 Alkylamido compounds and uses thereof
08/19/2010CA2752232A1 Combinational compositions and methods for treatment of cancer
08/19/2010CA2752211A1 Fibronectin type iii domain based scaffold compositions, methods and uses
08/19/2010CA2752136A1 Anti-mst1r antibodies and uses thereof
08/19/2010CA2752114A1 Fused pyrimidines as akt inhibitors
08/19/2010CA2751977A1 C-cbl and antagonists thereof for the treatment and diagnosis of cancer
08/19/2010CA2751886A1 Novel amino azaheterocyclic carboxamides
08/19/2010CA2751478A1 Derivatives of azaindoles as inhibitors of protein kinases abl and src
08/19/2010CA2751393A1 Pharmaceutical compositions of 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta (c)chromen-3-yl sulfamate
08/19/2010CA2751243A1 Spiroindolinone pyridine derivative
08/19/2010CA2749926A1 Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218719A1 Abcg2 inhibitor
08/18/2010EP2218716A1 Method for amplifying hematopoietic stem cells using heterocyclic compound
08/18/2010EP2218712A1 Combination of anti-angiogenic substance and anti-tumor platinum complex
08/18/2010EP2218461A1 CD40 antibody formulation and methods
08/18/2010EP2218451A1 Use of FTS for treating malignant disorders
08/18/2010EP2217706A2 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
08/18/2010EP2217611A1 Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
08/18/2010EP2217605A1 Compounds for inhibiting ksp kinesin activity
08/18/2010EP2217603A1 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 2
08/18/2010EP2217601A1 Imidazopyridazines for use as protein kinase inhibitors
08/18/2010EP2217595A1 Diamido thiazole derivatives as protein kinase inhibitors
08/18/2010EP2217580A2 Substituted tetrazole compounds and uses thereof
08/18/2010EP2217568A1 Compounds for inhibiting ksp kinesin activity
08/18/2010EP2217560A1 Novel synthetic analogs of sphingolipids
08/18/2010EP2217283A2 Biocompatible biodegradable fumagillin analog conjugates
08/18/2010EP2217258A1 Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
08/18/2010EP2217247A1 Novel synthesis of beta-nucleosides
08/18/2010EP2217240A1 Methods and compounds for preventing and treating a tumour
08/18/2010EP2217235A2 Inhibitors of pim protein kinases, compositions, and methods for treating cancer
08/18/2010EP2217234A2 Combinations of mek inhibitors with mtor inhibitors
1 ... 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 ... 2211